These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Interferon beta and multiple sclerosis: look at the evidence. Patti F; Reggio A Int J Clin Pract Suppl; 2002 Sep; (131):23-32. PubMed ID: 12564809 [TBL] [Abstract][Full Text] [Related]
26. Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study. Webb UH J Neurosci Nurs; 2008 Dec; 40(6):356-61. PubMed ID: 19170303 [TBL] [Abstract][Full Text] [Related]
27. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis. Goodkin DE West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569 [TBL] [Abstract][Full Text] [Related]
28. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269 [TBL] [Abstract][Full Text] [Related]
29. [Experience in the treatment of multiple sclerosis with interferon beta in Galicia]. Romero-López J; Seijo-Martínez M; Del Campo V; Amigo-Jorrín MC; Arias M; Cortés-Laíño JA; Dapena-Bolaño D; López-González FJ; Lorenzo-González JR; Marín-Sánchez M; Muñoz-García D; Ozaita-Arteche G; Prieto JM Rev Neurol; 2003 Dec 1-15; 37(11):1001-4. PubMed ID: 14669137 [TBL] [Abstract][Full Text] [Related]
30. Disease-modifying therapy in relapsing--remitting multiple sclerosis: efficacy is paramount. Cristiano E Int J Clin Pract Suppl; 2002 Sep; (131):3-7. PubMed ID: 12564806 [TBL] [Abstract][Full Text] [Related]
32. Therapy of multiple sclerosis in children and adolescents. Tenembaum SN Clin Neurol Neurosurg; 2010 Sep; 112(7):633-40. PubMed ID: 20471159 [TBL] [Abstract][Full Text] [Related]
33. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate. Neuhaus O; Stüve O; Archelos JJ; Hartung HP J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504 [TBL] [Abstract][Full Text] [Related]
37. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Pender MP; Wolfe NP Intern Med J; 2002 Nov; 32(11):554-63. PubMed ID: 12412939 [TBL] [Abstract][Full Text] [Related]
38. Rationale and design of the prospective and retrospective observational study of Avonex and Rebif (PROOF) for the treatment of relapsing-remitting multiple sclerosis. Murray TJ Curr Med Res Opin; 2004 Jan; 20(1):25-30. PubMed ID: 14741068 [TBL] [Abstract][Full Text] [Related]
39. Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis. Etemadifar M; Janghorbani M; Shaygannejad V Acta Neurol Scand; 2006 May; 113(5):283-7. PubMed ID: 16629762 [TBL] [Abstract][Full Text] [Related]